Cantor Fitzgerald has a convertible bond with Tether, incoming Commerce Secretary Howard Lutnick said at his confirmation hearing, confirming previous reporting by The Wall Street Journal that ...

On Monday, Cantor Fitzgerald reaffirmed its Overweight rating on Surgery Partners (NASDAQ:SGRY) with a steady price target of $36.00. The stock, which has shown significant momentum with a 20% ...

Cantor Fitzgerald analyst K. Kluska now expects that the biopharmaceutical company will earn ($3.26) per share for the year, down from their previous estimate of ($2.84).

On Tuesday, Cantor Fitzgerald reiterated its confidence in ORIC Pharmaceuticals (NASDAQ:ORIC), maintaining an Overweight stock rating. Trading at $11.49, ORIC has seen analyst targets ranging from ...

Cantor Fitzgerald raised the firm’s price target on PTC Therapeutics (PTCT) to $113 from $76 and keeps an Overweight rating on the shares. PTC has several regulatory decisions this year ...

In a report released yesterday, Troy Jensen from Cantor Fitzgerald reiterated a Buy rating on Proto Labs (PRLB – Research Report), with a price target of $50.00. The company’s shares closed ...

As previously reported last night, Cantor Fitzgerald initiated coverage of five Government Technology & Space, or “GovTech,” stocks, starting SAIC (SAIC) with a Neutral rating and $120 price ...

Shares of AMTM stock opened at $22.13 on Friday. Amentum has a one year low of $18.38 and a one year high of $34.50. The company has a quick ratio of 1.57, a current ratio of 1.59 and a debt-to ...

Howard Lutnick, the chairman of Cantor Fitzgerald and nominee for U.S. Commerce Secretary, faced questioning from Senate Democrats regarding the financial firm's investment in Tether, the entity ...

Eric Johnston, senior managing director at Cantor Fitzgerald, said he is bullish China equities (NYSEARCA:FXI), (MCHI), (GXC) in its bi-weekly equity and macro trading presentation. Cantor ...

Cantor Fitzgerald lowered the firm’s price target on Cigna (CI) to $350 from $400 and keeps an Overweight rating on the shares. Cantor is confident that Cigna can correct their stop-loss pricing ...

Brett Knoblauch, Cantor Fitzgerald head of digital asset research, joins 'Power Lunch' to discuss the energy needed to power AI in Stargate deal and the winners from it. Coast Guard Investigates ...